SEATTLE, May 8, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announces its financial results and provides an update on recent corporate developments for the first quarter ended March 31, 2026. "During the quarter, we made meaningful progress advancing our (Z)-endoxifen development strategy across both oncology and rare dise

OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the Company and certain accredited investors to exercise certain outstanding Class A, Class B, Class C, Class D, Class E and Class F Warrants (the “Existing Warrants”) to purchase up to an aggregate of 8,719,928 shares of common s

Summit PD-1xVEGF's interim trial miss, UCB's $2 billion acquisition of Candid Therapeutics, and J&J's CAR-T pipeline cull made our news this week. Summit Therapeutics' closely watched PD-1xVEGF study surprisingly missed its mark at an interim analysis. UCB will pay $2 billion upfront to buy Candid Therapeutics, which has aggregated a group of Chinese assets. Johnson & Johnson eliminated two CD20 CAR-T programs that it licensed from Sino-American biotech AbelZeta Pharma. And more.1.

FIREFLY-2 is the largest study ever conducted in front-line pLGG Trial aims to extend OJEMDA's indication beyond relapsed/refractory setting to address significant unmet need; topline data expected by mid-2027 BOSTON, May 8, 2026 /PRNewswire/ -- Day One Biopharmaceuticals, Inc., now part of Servier Group, today announced that it has completed enrollment in the FIREFLY-2 clinical trial, which is evaluating the efficacy, safety and tolerability of tovorafenib vs standard of care chemotherapy in th

The Modern Family duo star in a new video “The Mening-Itinerary,” which is available now on GSK’s YouTube channel. GSK is teaming up with “Modern Family” stars Julie Bowen and Ty Burrell to help get out the messaging: “ask to be sure” about the risks of meningococcal disease.This disease is most prevalent amongst teens and young adults, namely 16 to 23-year-olds, who have the highest rates of meningitis. There can also be small epidemic outbreaks at colleges and schools because of t

PLYMOUTH MEETING, Pa., May 8, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conferences: American Society of Gene and Cell Therapy Annual Meeting (Boston) Poster Presentation: Bleeding phenotype correction in hemophilia A mice following in vivo Factor VIII gene t

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board’s Compensation Committee and Technology Committee. Mr. Neubauer has achieved a distinguished career spanning three decades with B. Braun, including serving for

Platform, powered by AWS, connects patients, researchers, and clinicians to accelerate breakthroughs in gynecologic cancers NEW YORK, May 8, 2026 /PRNewswire/ -- Ovarian Cancer Research Alliance (OCRA) today announced the launch of the Community Accelerated Research Exchange, a first-of-its-kind, global, AI-powered ecosystem designed to transform how gynecologic cancer research is conducted—accelerating breakthroughs by connecting patients, clinicians, researchers, and advocates in real time. De

BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on May 4, 2026 to ten new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 563

Dr. Wilson joins an elite, invitation-only assembly of the nation's most influential health care leaders and policymakers shaping the future of American medicine GIG HARBOR, Wash., May 8, 2026 /PRNewswire/ -- NorthStar, a pioneering force in technology-enabled, evidence-based addiction treatment, today announced that Dr. Amanda Wilson, CEO and Co-Founder, has been appointed to The Washington Post Intelligence Health Care Council—an exclusive, invitation-only body of the most influential senior e